Download FREE Report Sample
Download Free sampleMigraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs.
Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.
Migraine Headache Drugs Market contains market size and forecasts of Migraine Headache Drugs in Global, including the following market information:
Global Migraine Headache Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Migraine Headache Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Almotriptan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Migraine Headache Drugs include Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Migraine Headache Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine Headache Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Migraine Headache Drugs Market Segment Percentages, by Type, 2021 (%)
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
Global Migraine Headache Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Migraine Headache Drugs Market Segment Percentages, by Application, 2021 (%)
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
Global Migraine Headache Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Migraine Headache Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Migraine Headache Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Migraine Headache Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex
Ajanta Pharma
Allergan
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
